Use of taxanes in the treatment of patients with breast cancer has increased dramatically over the past 8 years

Clin Breast Cancer. 2000 Jul;1(2):164-5.
No abstract available

Publication types

  • Letter
  • Review

MeSH terms

  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality
  • Breast Neoplasms / psychology
  • Docetaxel
  • Drug Utilization
  • Female
  • Humans
  • Medical Oncology / methods
  • Medical Oncology / statistics & numerical data
  • Paclitaxel / analogs & derivatives*
  • Paclitaxel / therapeutic use*
  • Patient Selection
  • Quality of Life
  • Survival Analysis
  • Taxoids*
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Phytogenic
  • Taxoids
  • Docetaxel
  • Paclitaxel